Year: 2011
Type: dissertation
Abstract: AKT1 v-akt murine thymoma viral oncogene homologue 1 AR androgen receptor BRFS biochemical recurrence-free survival CRPC castration-resistant prostate cancer CT computerized tomography DRE digital rectal examination DHT dihydrotestosterone ERG v-ets erythroblastosis virus E26 oncogene homolog (avian) ETV1 ETS variant 1 gene ETV4 ETS variant 4 gene ETV5 ETS variant 5 gene FISH fl uorescence in situ hybridization FOXP1 forkhead box P1 HDAC1 Histone deacetylase 1 HMBS Hydroxymethylbilane synthase IHC immunohistochemistry Kb kilobases LHRH luneinizing hormone-releasing hormone Mb megabases MRI magnetic resonance imaging PBGD Porphobilinogen deaminase PCR polymerase chain reaction PHD pleckstrin homology domain PI3K phosphatidylinositol 3-kinase PIN prostatic intraepithelial neoplasia PLND pelvic lymph node dissection PSA prostate-specifi c antigen PtdIns phosphorylated phosphoinositides PTEN phosphatase and tensin homologue RP radical prostatectomy RT-PCR reverse transcriptase polymerase chain reaction SPINK1 serine protease inhibitor Kazal type 1 TDRD1 tudor domain containing 1 TMPRSS2 transmembrane protease, serine 2 TNF tumour necrosis factor TNM tumour node metastasis TRUS transrectal ultrasound of the prostate TURP transurethral resection of the prostate
Author: Joost L. Boormans
Institution: Erasmus University Rotterdam
Language: English
Subfield: Cancer Research
Domain: Life Sciences
Keywords: prostate cancer, genetic alterations, prognostic factors, androgen receptor, AKT1, PTEN, TMPRSS2-ERG fusion, ETV1, ETV4, ETV5, SPINK1, PI3K signaling, androgen deprivation therapy, castration-resistant prostate cancer, biochemical recurrence, prostatic intraepithelial neoplasia, radical prostatectomy, salvage radiotherapy
Open Access status: green
Funder: AstraZeneca
OpenAlex ID: W1490159369
